Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|November 16, 2023
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinomaTimothy P DiPeri, Ming Zhao, Kurt W Evans, et al.
Cancer Research|February 5, 2013
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerBrett G Hollier, Agata A Tinnirello, Steven J Werden, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesJoseph H Taube, Jason I Herschkowitz, Kakajan Komurov, et al.
Cancer Discovery|February 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived XenograftsTimothy P DiPeri, Kurt W Evans, Bailiang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase InhibitionXian Chen, Kwang-Huei Low, Angela Alexander, et al.
RSC Medicinal Chemistry|June 11, 2025
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacyUjjwol Khatri, Neetu Dayal, Kofi B Owusu, et al.
Cancers|October 13, 2021
RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer PatientRozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract CancerTimothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
Plos One|September 2, 2015
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient OutcomesPriscilla F McAuliffe, Kurt W Evans, Argun Akcakanat, et al.
Cancer Research|September 14, 2021
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast CancerKurt W Evans, Erkan Yuca, Stephen S Scott, et al.
Pageof 4